BAb and MxA as functional biomarkers in routine clinical laboratories for the determination of anti-IFN-beta antibodies and their bioactivity levels in multiple sclerosis patients.

Cakal B., Uygunoglu U., SAIP S., ALTINTAS A., SIVA A., BADUR S.

Journal of immunoassay & immunochemistry, cilt.35, ss.398-411, 2014 (SCI-Expanded) identifier identifier